NO168110C - Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon - Google Patents

Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon

Info

Publication number: NO168110C
Authority: NO; Norway
Prior art keywords: inflammative; sterile; procedure; preparation; hyaluronic acid
Prior art date: 1986-03-21

Application number

NO871137A

Other languages

English (en)

Norwegian (no)

Other versions

NO871137D0 (no

NO871137L (no

NO168110B (no

Inventor

Jean Hildesheim

Original Assignee

Int Pharmaceutical Products In

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-03-21

Filing date

1987-03-19

Publication date

1992-01-15

1987-03-19 Application filed by Int Pharmaceutical Products In filed Critical Int Pharmaceutical Products In

1987-03-19 Publication of NO871137D0 publication Critical patent/NO871137D0/no

1987-09-22 Publication of NO871137L publication Critical patent/NO871137L/no

1991-10-07 Publication of NO168110B publication Critical patent/NO168110B/no

1992-01-15 Publication of NO168110C publication Critical patent/NO168110C/no

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
239000000061 acid fraction Substances 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Polymers & Plastics (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Materials Engineering (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Materials For Medical Uses (AREA)
Peptides Or Proteins (AREA)

NO871137A 1986-03-21 1987-03-19 Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon NO168110C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US84263486A	1986-03-21	1986-03-21

Publications (4)

Publication Number	Publication Date
NO871137D0 NO871137D0 (no)	1987-03-19
NO871137L NO871137L (no)	1987-09-22
NO168110B NO168110B (no)	1991-10-07
NO168110C true NO168110C (no)	1992-01-15

Family

ID=25287867

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO871137A NO168110C (no)	1986-03-21	1987-03-19	Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon

Country Status (8)

Country	Link
EP (1)	EP0239335A3 (de)
JP (1)	JPS62295901A (de)
KR (1)	KR910004518B1 (de)
AU (1)	AU600257B2 (de)
DK (1)	DK144987A (de)
IL (1)	IL81945A0 (de)
NO (1)	NO168110C (de)
ZA (1)	ZA871748B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE129254T1 (de) *	1987-03-19	1995-11-15	Arthropharm Pty Ltd	Antientzündungsmittel und zusammensetzungen.
US5668116A (en) *	1987-03-19	1997-09-16	Anthropharm Pty. Limited	Anti-inflammatory compounds and compositions
US5079236A (en) *	1987-05-27	1992-01-07	Hyal Pharmaceutical Corporation	Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
DE69018440T2 (de) *	1989-09-12	1995-08-10	Shiseido Co Ltd	Verfahren zur herstellung von hyaluronsäure mit niedrigem molekulargewicht.
IT1247175B (it) *	1991-04-19	1994-12-12	Fidia Spa	Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
US5621093A (en) *	1995-06-06	1997-04-15	Anika Research, Inc.	Steam-sterilizing solid hyaluronic acid
ITMI20082015A1 (it) *	2008-11-13	2010-05-14	Mac Pharma S R L	Acido ialuronico a basso contenuto di endotossine e ad elevata capacita' di assorbimento di acqua.
CZ301899B6 (cs) *	2009-03-17	2010-07-21	Contipro C, A.S.	Zpusob prípravy derivátu kyseliny hyaluronové pomocí O-acyl-O´-alkylkarbonátu v prítomnosti substituovaného pyridinu
JP6231993B2 (ja) *	2012-12-10	2017-11-15	三洋化成工業株式会社	ヒアルロン酸組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141973A (en) *	1975-10-17	1979-02-27	Biotrics, Inc.	Ultrapure hyaluronic acid and the use thereof
FR2553099B1 (fr) *	1983-10-11	1989-09-08	Fidia Spa	Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
US4879375A (en) *	1985-05-09	1989-11-07	Hill David Cullis	Preparation of hyaluronic acid from synovial fluid
US4851521A (en) *	1985-07-08	1989-07-25	Fidia, S.P.A.	Esters of hyaluronic acid

1987
- 1987-02-27 AU AU69558/87A patent/AU600257B2/en not_active Ceased
- 1987-03-03 KR KR1019870001883A patent/KR910004518B1/ko not_active Expired
- 1987-03-11 ZA ZA871748A patent/ZA871748B/xx unknown
- 1987-03-19 NO NO871137A patent/NO168110C/no unknown
- 1987-03-19 IL IL81945A patent/IL81945A0/xx unknown
- 1987-03-20 EP EP87302432A patent/EP0239335A3/de not_active Withdrawn
- 1987-03-20 DK DK144987A patent/DK144987A/da unknown
- 1987-03-20 JP JP62064448A patent/JPS62295901A/ja active Pending

Also Published As

Publication number	Publication date
JPS62295901A (ja)	1987-12-23
NO871137D0 (no)	1987-03-19
DK144987D0 (da)	1987-03-20
NO871137L (no)	1987-09-22
IL81945A0 (en)	1987-10-20
AU600257B2 (en)	1990-08-09
EP0239335A3 (de)	1988-07-27
KR870008904A (ko)	1987-10-22
KR910004518B1 (ko)	1991-07-05
ZA871748B (en)	1987-08-31
EP0239335A2 (de)	1987-09-30
NO168110B (no)	1991-10-07
DK144987A (da)	1987-09-22
AU6955887A (en)	1987-09-24

Similar Documents

Publication	Publication Date	Title
NO871408L (no)	1987-10-05	Forbedringer ved farmasoeytiske akseptable salter.
NO875082L (no)	1988-06-09	Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO873598L (no)	1988-02-29	Kirurgisk protese.
FR2599961B1 (fr)	1994-01-21	Piece a main medicale a laser.
NO166639C (no)	1991-08-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
DK549989A (da)	1990-05-05	Fremgangsmaade til fremstilling af en steril, konserveringsmiddelfri aerosoloploesning
DK164637C (da)	1992-12-14	Fremgangsmaade til fremstilling af et hudplejemiddel i form af en steril alkoholisk ekstrakt
NO171909C (no)	1993-05-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
DK155714C (da)	1989-10-30	Fremgangsmaade til fremstilling af en steril, injicerbar, fysiologisk acceptabel oploesning af et roentgenkontrastmiddel, samt en oploesning af roentgenkontrastmidlet til brug ved fremgangsmaaden
NO168654C (no)	1992-03-18	Fremgangsmaate for polymerisering av 1,3-butadien.
NO168110C (no)	1992-01-15	Fremgangsmaate for fremstilling av en steril, ikke betennelses-fremkallende, varmeresistent hyaluronsyrefraksjon
NO168107C (no)	1992-01-15	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
NO870866D0 (no)	1987-03-03	Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat.
NO166326C (no)	1991-07-03	Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
FI874166A7 (fi)	1988-03-25	2',3'-dideoksisytidin-2'-eenin käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
NO874850D0 (no)	1987-11-20	Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO873923L (no)	1988-03-21	Fremgangsmaate for fremstilling av et medisinsk hudpreparat
NO884018D0 (no)	1988-09-09	Fremgangsmaate for fremstilling av en friradikaladdisjonspolymer.
NO881510D0 (no)	1988-04-07	Sterilt formeringssystem.
DK103987A (da)	1987-09-12	Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
FI890779L (fi)	1989-02-17	14,17 -etano-14 -estratrieenejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä, ehkäisyaineina käytettäviä valmisteita
DK425287A (da)	1988-02-29	Fremstilling af et farmaceutisk praeparat til behandling af kongestivt hjertesvigt
NO862390D0 (no)	1986-06-16	Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
ES2019053A4 (es)	1991-06-01	Centro quirurgico modular ambulatorio.
FI881123L (fi)	1988-09-13	Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.